PDCD4-IN-1

CAS No. 494763-64-3

PDCD4-IN-1( —— )

Catalog No. M36425 CAS No. 494763-64-3

PDCD4-IN-1, a PDCD4 inhibitor (Kd : 350 nM), promotes BDNF expression in hippocampal neuronal cells HT-22.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 45 Get Quote
10MG 76 Get Quote
25MG 150 Get Quote
50MG 242 Get Quote
100MG 372 Get Quote
500MG 849 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    PDCD4-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    PDCD4-IN-1, a PDCD4 inhibitor (Kd : 350 nM), promotes BDNF expression in hippocampal neuronal cells HT-22.
  • Description
    PDCD4-IN-1(compound 20031600) is a PDCD4 inhibitor with a Kd value of 350 nM, which can promote the expression of BDNF in hippocampal neuron cell HT-22.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    494763-64-3
  • Formula Weight
    326.58
  • Molecular Formula
    C12H9BrClN3O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 250 mg/mL (765.51 mM; Ultrasonic )
  • SMILES
    C(NNC1=CC(Cl)=CC=C1)(=O)C=2C=C(Br)C=NC2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Application of ligand small molecule of targeting PDCD4 in preparation of antidepressant drugs. CN115385914.
molnova catalog
related products
  • Clobetasone butyrate

    Clobetasone butyrate can be used to relieve corticosteroid-responsive dermatoses, including atopic?dermatitis and psoriasis.

  • MUN36378

    MUN36378 is a FTO inhibitor for treatment of leukemia.

  • Heliotrine N-oxide

    Heliotrine N-oxide is the pyrrolizidine alkaloid (PA) N-oxide counterpart of Heliotrine. It induces the generation of pyrrolic DNA adducts, potentially initiating PA-induced liver tumors in vivo.